Search - tctmd.com

Displaying 41 - 60 of 77

Sort: Relevancy | Date

Presentation NY Valves 2024

Female Sex Is Not Associated With Increased Vascular Afterload in Older Patients With Aortic Stenosis

Presenter: Sara Hungerford

June 06, 2024

Presentation NY Valves 2024

The Landscape of Novel Methods to Screen for VHD

Presenter: Sreekanth Vemulapalli

June 06, 2024

Presentation NY Valves 2024

Invasive Versus Echocardiographic Transvalvular Pressure Gradients After Transcatheter Aortic Valve Implantation

Presenter: Eishan Ashwat

June 06, 2024

Presentation NY Valves 2024

Invasive Exercise Hemodynamics in Aortic Stenosis

Presenter: Abdullah Al-Abcha

June 06, 2024

Presentation NY Valves 2024

The Importance of Patient Reported Outcomes in VHD

Presenter: Suzanne V. Arnold

June 06, 2024

Presentation NY Valves 2024

Diversity and Under Represented Populations in VHD: Focusing on Real Solutions

Presenter: Annetine C. Gelijns, Megan Coylewright

June 06, 2024

Presentation NY Valves 2024

Using Real-world Data in VHD: Sources, Successes, and Failures

Presenter: Sreekanth Vemulapalli

June 06, 2024

Presentation NY Valves 2024

Long-term Follow-up in VHD Clinical Trials: Much Needed, BUT Difficult to Do

Presenter: Mauro Moscucci

June 06, 2024

Presentation NY Valves 2024

Challenges With Vulnerable, Underrepresented Populations

Presenter: Clyde W. Yancy

June 06, 2024

Presentation NY Valves 2024

Trialist Perspective

Presenter: Roxana Mehran

June 06, 2024

Presentation NY Valves 2024

Industry Perspective

Presenter: Janarthanan Sathananthan

June 06, 2024

Presentation NY Valves 2024

FDA Perspective

Presenter: Lisa Plummer

June 06, 2024

Presentation NY Valves 2024

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Presenter: Donna Mancini

June 05, 2024

Presentation NY Valves 2024

Medical Management Post AVR

Presenter: Javed Butler

June 05, 2024

Presentation NY Valves 2024

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Presenter: Parag Goyal

June 05, 2024

Presentation NY Valves 2024

Case Presentation: Aortic Stenosis and Dyspnea – What Do We Call It? Is It HFpEF OR Is It the Valve?

Presenter: Kyle R. Lehenbauer

June 05, 2024

Presentation NY Valves 2024

Current and Future use of Artificial Intelligence in Echocardiography

Presenter: Akhil Narang

June 05, 2024

Presentation NY Valves 2024

Echocardiographic Speckle Strain Imaging and Valvular Heart Disease Outcomes

Presenter: Madalina Garbi

June 05, 2024

Presentation NY Valves 2024

Revolutionizing Valvular Disease Diagnosis: Empowering Non-Cardiology Practitioners With AI-Augmented POCUS

Presenter: Elad Maor

June 05, 2024

Presentation NY Valves 2024

Unleashing the Potential of CMR and CT: Myocardial Risk Stratification for VHD

Presenter: Omar K. Khalique

June 05, 2024

Advertisement

Female Sex Is Not Associated With Increased Vascular Afterload in Older Patients With Aortic Stenosis

The Landscape of Novel Methods to Screen for VHD

Invasive Versus Echocardiographic Transvalvular Pressure Gradients After Transcatheter Aortic Valve Implantation

Invasive Exercise Hemodynamics in Aortic Stenosis

The Importance of Patient Reported Outcomes in VHD

Diversity and Under Represented Populations in VHD: Focusing on Real Solutions

Using Real-world Data in VHD: Sources, Successes, and Failures

Long-term Follow-up in VHD Clinical Trials: Much Needed, BUT Difficult to Do

Challenges With Vulnerable, Underrepresented Populations

Trialist Perspective

Industry Perspective

FDA Perspective

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Medical Management Post AVR

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Case Presentation: Aortic Stenosis and Dyspnea – What Do We Call It? Is It HFpEF OR Is It the Valve?

Current and Future use of Artificial Intelligence in Echocardiography

Echocardiographic Speckle Strain Imaging and Valvular Heart Disease Outcomes

Revolutionizing Valvular Disease Diagnosis: Empowering Non-Cardiology Practitioners With AI-Augmented POCUS

Unleashing the Potential of CMR and CT: Myocardial Risk Stratification for VHD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content